antiarrhythmic therapy, the pooled estimate showed a trend towards reduced VT recurrence (HR ∼0.61; 95% CI: 0.45–0.82; Figure 6 ).
← all excerpts
Heterogeneity of outcomes reporting in catheter ablation trials for ventricular tachycardia: a systematic review.
1
—
—